Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent steps he has taken to promote early detection of treatable diseases amongst (a) the public and (b) healthcare workers.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Each year, over 15 million people are invited for screening, with over 10 million taking up the invitation. In total, this saves approximately 10,000 lives every year and enables many others to make better informed decisions around their health.

The Government delivers 11 screening programmes to detect 33 treatable conditions. The antenatal screening programme also provides information for couples about their baby.

On 14 October 2025, NHS England announced that newborn screening for the rare, life-threatening metabolic disorder hereditary tyrosinaemia type 1 is now being offered to all babies in England.

In early 2026, screening providers will also be able to offer human papillomavirus self-sampling kits to under-screened individuals in the National Health Service cervical screening programme in England. Evidence suggests that self-sampling will increase the numbers engaging with the screening programme.

In addition to this, the Government continues to deliver the NHS Health Check, a core component of England’s cardiovascular disease prevention programme, which aims to detect those at risk of heart disease, stroke, type 2 diabetes, and kidney disease for people aged between 40 to 74 years old. In 2024/25, the NHS Health Check engaged over 1.4 million people and prevented an estimated 500 heart attacks and strokes. To improve access to the programme we are piloting an online NHS Health Check so that people can undertake a check at a time and place convenient to them.

Employers across the NHS have their own arrangements in place for supporting their staff, including occupational health provision, employee support programmes, and board level scrutiny through health and wellbeing guardians.

We will also roll out Staff Treatment hubs to ensure that staff have access to high quality support for mental health and back conditions.

At a national level, NHS England has made additional support available. This includes a focus on healthy working environments, tools and resources to support line managers to hold meaningful conversations with staff to discuss their wellbeing, and emotional and psychological health and wellbeing support.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent steps he has taken to help (a) increase the proportion of people with asthma that receive annual check-ups and (b) decrease preventable deaths from asthma.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The majority of patients with asthma are managed by general practitioners and members of the primary care team, with onward referrals to secondary care where required. The provision of annual reviews is incentivised in primary care through the Quality and Outcomes Framework (QOF). Further details on the QOF asthma indicators are available in the QOF guidance, a copy of which is attached.

In addition, the National Institute for Health and Care Excellence, the British Thoracic Society, and the Scottish Intercollegiate Guidelines Network published the guideline Asthma: diagnosis, monitoring and chronic asthma management, in November 2024, which covers diagnosing, monitoring, and managing asthma in adults, young people, and children. NHS England has also been working jointly with the Health Innovation Networks to form a national respiratory partnership to improve asthma outcomes, including through implementation of this asthma guideline.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to increase awareness of the (a) signs and (b) symptoms of mouth cancer.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

NHS England runs Help Us Help You campaigns in England to increase knowledge of cancer symptoms and to address barriers to acting on them, to encourage people to come forward as soon as possible to see their general practitioner. The campaigns focus on a range of symptoms, as well as encouraging body awareness, to help people spot symptoms across a wide range of cancers at an earlier point.

NHS England and other National Health Service organisations, nationally and locally, publish information on the signs and symptoms of many different types of cancer, including mouth cancer. This information can be found at sources like the NHS.UK website, which is available at the following link:

https://www.nhs.uk/

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what discussions has she had with Israeli counterparts on (a) military strikes, (b) the destruction of buildings and (c) aid restrictions in Gaza since the implementation of the ceasefire.

Answered by Hamish Falconer - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

I refer the Hon. Member to the responses I gave during the Urgent Question debate on Gaza in the House of Commons on 29 October, Official Report, vol. 774, cols. 311-325.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent discussions his Department has had with stakeholders on compensation for people affected by in-utero exposure to sodium valproate.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is carefully considering the work by the Patient Safety Commissioner and her report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex issue involving input from different Government departments. The Government will provide a further update to the Patient Safety Commissioner’s report.

The Department will consider further meetings with the community and relevant stakeholders, when we have a substantive update to ensure that discussions can be productive, as part of our work on these important issues.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will implement standardised regulations for the (a) collection and (b) storage of rare cancer tissue samples obtained for the purposes of (i) medical treatment and (ii) future research.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Human Tissue Authority (HTA) regulates organisations that remove, store, and use human tissue for scheduled purposes, including research and medical treatment.

Under the Human Tissue Act 2004, appropriate consent is always required to remove tissue from the deceased for research purposes. Tissue from living patients, for example biopsy or blood samples, can ordinarily be used for research only with the person's consent. The HTA ensures that it is removed and stored in an appropriate and well managed way.

Consent is not required for research on tissue from living patients if the samples are anonymised or coded to make sure patient or participant information is not identifiable, and the project has recognised ethics committee approval, or if the tissue samples were obtained before 1 September 2006, when the Human Tissue Act came into force.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make it his policy to hold further meetings with (a) people affected by in-utero exposure to sodium valproate and (b) other relevant stakeholders on the progress made in implementing the recommendations outlined in the Hughes Report.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is carefully considering the work by the Patient Safety Commissioner and her report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex issue involving input from different Government departments. The Government will provide a further update to the Patient Safety Commissioner’s report.

The Department will consider further meetings with the community and relevant stakeholders, when we have a substantive update to ensure that discussions can be productive, as part of our work on these important issues.

Question to the Department for Transport:

To ask the Secretary of State for Transport, with reference to her Department's consultation entitled The third cycling and walking investment strategy (CWIS), published on 3 November 2025, if she will set out the percentage increase in the level of walking and cycling stages per person by 2030 necessary to achieve the CWIS3 objective.

Answered by Lilian Greenwood - Government Whip, Lord Commissioner of HM Treasury

The consultation on the third Cycling and Walking Investment Strategy, is seeking the views of stakeholders on a national vision, statutory objectives and underlying performance indicators. The shape of the final strategy, intended to be published, next year including targets concerning walking and cycling stages, will be informed by the responses to the consultation.

Domestic Energy Efficiency (Call for Evidence) Bill

Thanking postal workers

Sodium valproate and surgical mesh redress

Crohn’s and Colitis Awareness Week 2025

68 Is Too Late report by the Prison Officers' Association

Armed Forces Training Contract and Elbit Systems